US equities |
TSLA $362.44 ▲+0.00% MU $931.24 ▲+0.00% SPCX $148.62 ▲+0.00% SNDK $1,394.83 ▲+0.00% SKHY $146.11 ▲+0.00% NVDA $217.23 ▲+0.00% AMD $562.23 ▲+0.00% INTC $95.22 ▼-0.16%
FinancialContent

Articles published by Lyra Therapeutics, Inc.

News headline image
Lyra Therapeutics Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for LYR-210 for the Treatment of Chronic Rhinosinusitis
From Lyra Therapeutics, Inc.
Via Business Wire
Tickers LYRA
News headline image
Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets
From Lyra Therapeutics, Inc.
Via Business Wire
Tickers LYRA
News headline image
Lyra Therapeutics to Present at the William Blair 41st Annual Growth Stock Conference
From Lyra Therapeutics, Inc.
Via Business Wire
Tickers LYRA
News headline image
Lyra Therapeutics To Present At The Jefferies Virtual Healthcare Conference
From Lyra Therapeutics, Inc.
Via Business Wire
Tickers LYRA
News headline image
Lyra Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
From Lyra Therapeutics, Inc.
Via Business Wire
Tickers LYRA
News headline image
Lyra Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference
From Lyra Therapeutics, Inc.
Via Business Wire
Tickers LYRA
News headline image
Lyra Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update
From Lyra Therapeutics, Inc.
Via Business Wire
Tickers LYRA
News headline image
Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual
From Lyra Therapeutics, Inc.
Via Business Wire
Tickers LYRA